'Multiple Sclerosis - Pipeline Review, H1 2015', provides an overview of the Multiple Sclerosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Multiple Sclerosis, complete with comparative analysis at various stages.
The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.
Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Report: www.rnrmarketresearch.com/contact…ame=403529 . (This is a premium report price at US$2500 for a single user PDF license)
Company profiles mentioned in this report are Acadia Pharmaceuticals Inc., Affectis Pharmaceuticals AG, Allozyne, Inc., Antisense Therapeutics Limited, Arena Pharmaceuticals, Inc., Compugen Ltd., Digna Biotech, S.L., Eisai Co., Ltd., Forward Pharma A/S, Genzyme Corporation, Harbor Therapeutics, Inc., Inbiopro Solutions Pvt. Ltd., Kadmon Corporation, LLC, Mapi Pharma Ltd., Pfenex Inc., Synthetic Biologics, Inc., Virogenomics, Inc., Zydus Cadila Healthcare Limited.
Scope
- The report provides a snapshot of the global therapeutic landscape of Multiple Sclerosis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Multiple Sclerosis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Multiple Sclerosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
For more information:
News From
RnR Market Research Category: Industry Reports & Market Analysis Profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
